These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Deleu D Neurology; 2002 Mar; 58(5):835-6; author reply 836. PubMed ID: 11889261 [No Abstract] [Full Text] [Related]
4. Donepezil for Alzheimer's disease? Drug Ther Bull; 1997 Oct; 35(10):75-6. PubMed ID: 9489056 [No Abstract] [Full Text] [Related]
5. AD2000: donepezil in Alzheimer's disease. Schneider LS Lancet; 2004 Jun; 363(9427):2100-1. PubMed ID: 15220027 [No Abstract] [Full Text] [Related]
6. Continuing donepezil produces cognitive benefits in Alzheimer's. Bland P Practitioner; 2012 Apr; 256(1750):5. PubMed ID: 22792683 [No Abstract] [Full Text] [Related]
7. Comparative study of donepezil and rivastigmine. Grossberg G Int J Clin Pract; 2003; 57(1):70-1; author reply 71. PubMed ID: 12587950 [No Abstract] [Full Text] [Related]
8. Donepezil delay to nursing home placement study is flawed. Karlawish JH J Am Geriatr Soc; 2004 May; 52(5):845; author reply 845-6. PubMed ID: 15086676 [No Abstract] [Full Text] [Related]
9. Top cited papers in international psychogeriatrics: 3. Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's disease. Gauthier S; O'Brien J Int Psychogeriatr; 2009 Jun; 21(3):454-6. PubMed ID: 19371449 [No Abstract] [Full Text] [Related]
10. Donepezil for severe Alzheimer's disease. Hogan DB Lancet; 2006 Apr; 367(9516):1031-1032. PubMed ID: 16581383 [No Abstract] [Full Text] [Related]
11. Continuing donepezil when Alzheimer symptoms worsen might delay nursing home admission, study indicates. Torjesen I BMJ; 2015 Oct; 351():h5739. PubMed ID: 26506953 [No Abstract] [Full Text] [Related]
12. Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice? Tinklenberg JR; Kraemer HC; Yaffe K; Ross L; Sheikh J; Ashford JW; Yesavage JA; Taylor JL Am J Geriatr Psychiatry; 2007 Nov; 15(11):953-60. PubMed ID: 17974866 [TBL] [Abstract][Full Text] [Related]
13. Clinical inquiries. Does treatment with donepezil improve memory for patients with mild cognitive impairment? Stiles MM; Martin S; Persons RK J Fam Pract; 2006 May; 55(5):435-6. PubMed ID: 16670040 [No Abstract] [Full Text] [Related]
16. Comments on the article by Mazza et al. concerning Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study. Korczyn AD Eur J Neurol; 2007 Sep; 14(9):e9; author reply e10. PubMed ID: 17718684 [No Abstract] [Full Text] [Related]
17. Does donepezil improve well-being for dementia due to Alzheimer's disease? Birks J Neuroepidemiology; 2005; 24(3):168-9. PubMed ID: 15677877 [No Abstract] [Full Text] [Related]
18. Galantamine vs donepezil in the treatment of Alzheimer's disease. Goldlist B; Gordon M; Naglie G Drugs Aging; 2003; 20(15):1139-40; author reply 1140. PubMed ID: 14651439 [No Abstract] [Full Text] [Related]
19. Drug and Therapeutics Bulletin defends its stance over donepezil. Collier J BMJ; 1998 Apr; 316(7137):1092. PubMed ID: 9558999 [No Abstract] [Full Text] [Related]